Apogee Therapeutics, Inc Common Stock

Apogee Therapeutics, Inc Common Stock

Yahoo Finance • 3 days ago

Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026?

Key Points Invesco Pharmaceuticals ETF offers a higher dividend yield and lower five-year beta than State Street SPDR S&P Biotech ETF State Street SPDR S&P Biotech ETF holds 155 securities compared to 30 in Invesco Pharmaceuticals ETF Inv... Full story

Yahoo Finance • 12 days ago

This Pharmaceutical Giant Just Poured $11 Billion on an Acquisition. Time to Buy?

Key Points AbbVie recently announced an acquisition that may help it remain a leader in immunology. Between AbbVie's strong lineup, deep pipeline, and dividend program, there are many reasons to buy the stock.10 stocks we like better than... Full story

Yahoo Finance • 15 days ago

AbbVie (ABBV) Wins Health Canada Approval for Boey

AbbVie Inc. (NYSE:ABBV) is one of the 12 Most Profitable S&P 500 Stocks to Invest In. On June 23, 2026, Allergan Aesthetics, an AbbVie Inc. (NYSE:ABBV) company, announced that Health Canada approved Boey for the temporary improvement of m... Full story

Yahoo Finance • 15 days ago

AbbVie (ABBV) to Acquire Apogee Therapeutics

AbbVie Inc. (NYSE:ABBV) is one of the top trending US stocks to buy now. AbbVie Inc. (NYSE:ABBV) and Apogee Therapeutics announced on June 22 their entry into a definitive agreement under which AbbVie Inc. (NYSE:ABBV) will acquire Apogee a... Full story

Yahoo Finance • 15 days ago

2 Biotech Stocks Worth Buying Before Their Potential Buyouts

Dealmaking is back with a vengeance in the pharmaceutical sector this year. According to a report by PwC, there were more than $65 billion in pharma and life sciences mergers & acquisitions in the first quarter, the best quarter for the se... Full story

Yahoo Finance • 17 days ago

AbbVie vs. Pfizer: Which Pharma Giant Stock Is a Better Buy in 2026?

Key Points AbbVie is aggressively expanding its pipeline to offset the impact of biosimilar competition for its top-selling drugs. Pfizer is utilizing substantial capital for acquisitions to diversify its revenue stream and combat upcomin... Full story

Yahoo Finance • 18 days ago

Canaccord Says AbbVie’s (ABBV) Apogee Deal Strengthens Long-Term Growth Outlook

AbbVie Inc. (NYSE:ABBV) is included among the Top 10 Blue Chip Stocks with Growing Dividends.Canaccord Says AbbVie's (ABBV) Apogee Deal Strengthens Long-Term Growth Outlook On June 23, Canaccord raised its price recommendation on AbbVie I... Full story

Yahoo Finance • 19 days ago

Halper Sadeh LLC is Investigating Whether APGE, LPRO, HUN, AVNS are Obtaining Fair Deals for their Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. Shareholders are encouraged to contact the firm... Full story

Yahoo Finance • 19 days ago

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

Quick Read AbbVie (ABBV) proved big pharma will pay up for late-stage immunology with the Apogee deal, reigniting M&A speculation across the biotech sector. Syndax (SNDX) earns the top takeover ranking with two FDA-approved drugs, 224% re... Full story

Yahoo Finance • 20 days ago

Apogee Therapeutics (APGE) Hits Fresh High on AbbVie $10.9B Merger

Apogee Therapeutics Inc. (NASDAQ:APGE) is one of the 10 Stocks Paying Off Big Time. Apogee Therapeutics soared to a fresh all-time high on Monday, as investors gobbled up shares following announcements that it is set to be acquired by pha... Full story

Yahoo Finance • 20 days ago

Stocks Mostly Lower on Weakness in Megacap Tech and Software Stocks

The S&P 500 Index ($SPX) (SPY) on Monday closed down -0.37%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.29%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed down -0.19%.  September E-mini S&P futures (ESU26) fell -0.34%, and... Full story

Yahoo Finance • 20 days ago

Abbvie acquiring Apogee for $10.9B, Coca-Cola vs. IRS in appeals court

Yahoo Finance Senior Reporter Brooke DiPalma joins Josh Lipton in highlighting the day's biggest stories and stock moves, including AbbVie's (ABBV) $10.9 billion acquisition of Apogee Therapeutics (APGE) and Coca-Cola's (KO) latest legal s... Full story

Yahoo Finance • 20 days ago

Sector Update: Healthcare Stocks Rise Late Afternoon

Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.9% and PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 20 days ago

AbbVie's $10.9 Billion Apogee Deal Joins a $200 Billion Pharma Spree

This article first appeared on GuruFocus. AbbVie (NYSE:ABBV) rose 4.92% intraday after the drugmaker agreed to acquire Apogee Therapeutics (NASDAQ:APGE) for $10.9 billion in cash, offering $135.11 per share, a 49% premium to Apogee's Thur... Full story

Yahoo Finance • 20 days ago

Top Midday Gainers

Nexentis Technologies (NXTS) said Monday its subsidiary, MitoCareX Bio, has entered into an engageme PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 20 days ago

Stocks Erase Early Gains as Alphabet and Software Companies Fall

The S&P 500 Index ($SPX) (SPY) today is down -0.40%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.27%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.30%.  September E-mini S&P futures (ESU26) are down -0.38%, and September E... Full story

Yahoo Finance • 20 days ago

AbbVie (ABBV) Is Buying Apogee Therapeutics For $10.9 Billion

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. AbbVie (NYSE:ABBV) has agreed to acquire Apogee Therapeutics in a cash deal valued at US$10.9b. The transaction focuses on... Full story

Yahoo Finance • 20 days ago

Stocks Supported by Strength in Chipmakers and AI-Infrastructure Stocks

The S&P 500 Index ($SPX) (SPY) today is up +0.21%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +0.54%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.50%.  September E-mini S&P futures (ESU26) are up +0.20%, and September E-mini... Full story

Yahoo Finance • 20 days ago

AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers

On this episode of Stock Movers with Nathan Hager:- Apogee (APGE) shares are soaring on news AbbVie is closing in on a nearly $11 billion deal to buy inflammatory disease drug developer Apogee Therapeutics. That's also according to a Finan... Full story

Yahoo Finance • 20 days ago

Why AbbVie Is Spending $11 Billion to Buy Apogee Therapeutics

AbbVie will acquire the clinical-stage biotech’s pipeline of candidates for inflammatory and immunological diseases. Continue Reading... Full story